![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Howard Hughes Medical Institute, University of California, Berkeley 94720.
Abstract
Dissection of the cell-type-specific activation region in c-Jun reveals two functionally separable regulatory subdomains. One subdomain (a1) functions as a transcriptional activator; adjacent to it is a newly identified domain (epsilon) which, together with the previously defined delta region, interacts with a cellular factor that modulates the action of a1. Mutants that lack epsilon are constitutively active and do not interact with the cell-type-specific repressor, whereas mutants that have sustained changes in a1 exhibit a reduced trans-activation potential but retain the ability to interact with the repressor. This bipartite and modular organization of the a1/epsilon domain is further established by demonstrating that a1 can be replaced by the heterologous acidic activator of VP16 and retain proper negative regulation by the cell-specific c-Jun inhibitor along with epsilon and delta. Repression of Jun activity by the inhibitor is not caused by a change in stability, nuclear localization, or DNA-binding activity of the protein. Instead the inhibitor apparently regulates transcriptional activation by interacting directly with delta/epsilon and perhaps masking the a1 domain. These studies suggest that multifunctional activation domains, which are structurally complex, may play an important role in the mechanisms that govern inducible tissue-specific gene expression.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  K. N. Farrow, A. P. Bradford, J. J. Tentler, and A. Gutierrez-Hartmann Structural and Functional Analysis of the Differential Effects of c-Jun and v-Jun on Prolactin Gene Expression Mol. Endocrinol., October 1, 2004; 18(10): 2479 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. De Cesare, G. M. Fimia, S. Brancorsini, M. Parvinen, and P. Sassone-Corsi Transcriptional Control in Male Germ Cells: General Factor TFIIA Participates in CREM-Dependent Gene Activation Mol. Endocrinol., December 1, 2003; 17(12): 2554 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Munz, E. Psichari, D. Mandilis, A.-C. Lavigne, M. Spiliotaki, T. Oehler, I. Davidson, L. Tora, P. Angel, and A. Pintzas TAF7 (TAFII55) Plays a Role in the Transcription Activation by c-Jun J. Biol. Chem., June 6, 2003; 278(24): 21510 - 21516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding Mol. Cell. Biol., May 1, 2000; 20(9): 3102 - 3115. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Murai, H. Murakami, and S. Nagata Myeloid-specific transcriptional activation by murine myeloid zinc-finger protein 2 PNAS, March 31, 1998; 95(7): 3461 - 3466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Hovland, R. L. Powell, G. S. Takimoto, L. Tung, and K. B. Horwitz An N-terminal Inhibitory Function, IF, Suppresses Transcription by the A-isoform but Not the B-isoform of Human Progesterone Receptors J. Biol. Chem., March 6, 1998; 273(10): 5455 - 5460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hibi, A Lin, T Smeal, A Minden, and M Karin Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes & Dev., November 1, 1993; 7(11): 2135 - 2148. [Abstract] [PDF]
|
|
